ARDANT PHARMACEUTICALS LTD.
Registered officeUnit 1 Vanguard Industrial Estate, Henwood, Ashford, England, TN24 8DH and it is in the process of being changed to 3rd Floor, 37 Frederick Place, Brighton, BN1 4EA
Principal trading addressUnit 1 Vanguard Industrial Estate, Henwood, TN24 8DH
Notice is hereby given, pursuant to Section 100 of the Insolvency Act 1986 and Rules 6.14 and 15.8 of the Insolvency (England & Wales) Rules 2016 that a virtual meeting of the creditors of the above named company has been convened by James Anthony Aylott, the director of the company in accordance with resolutions passed by the Board of Directors.
The virtual meeting will be held at 11.30 am on 9 December 2025. To access the virtual meeting, which will be held via an online conferencing platform, please contact Quantuma Advisory Limited, on behalf of the convener – details below.
This virtual meeting will be recorded video and/or audio in order to establish and maintain records of the existence of relevant facts or decisions that are taken at the meeting. By attending this meeting, you consent to being recorded including recordings of your facial image. Where any recording of the meeting also entails the processing of personal data, such personal data shall be treated in accordance with the Data Protection Act 2018.
A meeting of shareholders has been called and will be held prior to the virtual meeting of creditors to consider passing a resolution for voluntary winding up of the Company. Any creditor entitled to attend and vote at this virtual meeting is entitled to do so either in person or by proxy. Creditors wishing to vote at the virtual meeting must (unless they are individual creditors attending in person) lodge their proxy with the convener before they may be used at the meeting.
Unless there are exceptional circumstances, a creditor will not be entitled to vote unless his written statement of claim, (‘proof’), which clearly sets out the name and address of the creditor and the amount claimed, has been lodged and admitted for voting purposes. Proofs must be delivered by 4pm the business day before the meeting. Unless they surrender their security, secured creditors must give particulars of their security, the date when it was given and the estimated value at which it is assessed if they wish to vote at the meeting.
The resolutions to be taken at the creditors’ meeting may include the appointment by creditors of Liquidators, a resolution specifying the terms on which the Liquidators are to be remunerated, and the meeting may receive information about, or be called upon to approve, the costs of preparing the statement of affairs and convening the procedure to seek a decision from creditors on the nomination of Liquidators.
Brian Burke and Marc Norman (IP no’s 16250 and 31890) are qualified to act as Insolvency Practitioners in relation to the above Company and during the period before the decision date they will furnish creditors free of charge with such information concerning the Company’s affairs as they may reasonably require.
In case of queries, please contact Edward Allingham on 01273 322 415 or on email Edward.Allingham@quantuma.com.
James Anthony Aylott, Director/Convener
28 November 2025
Ag KK90011
Recorded in The Gazette, issue 64920, 2 December 2025